Detalhe da pesquisa
1.
Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps.
Cell
; 184(26): 6262-6280.e26, 2021 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910928
2.
HACER: an atlas of human active enhancers to interpret regulatory variants.
Nucleic Acids Res
; 47(D1): D106-D112, 2019 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30247654
3.
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
Cancer
; 123(21): 4099-4105, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28743157
4.
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
Cancer
; 122(5): 766-72, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26695526
5.
Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Cancer
; 121(3): 448-56, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25273224
6.
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
JAMA
; 311(19): 1998-2006, 2014 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24846037
7.
Association between Estrogen Exposure and Idiopathic Subglottic Stenosis.
Laryngoscope
; 134(2): 825-830, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668331
8.
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors.
JTO Clin Res Rep
; 5(2): 100619, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328473
9.
Features of tumor-microenvironment images predict targeted therapy survival benefit in patients with EGFR-mutant lung cancer.
J Clin Invest
; 133(2)2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647832
10.
Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.
JAMA Netw Open
; 5(8): e2227211, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976648
11.
Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit.
J Thorac Oncol
; 17(12): 1365-1374, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36049656
12.
Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.
Ann Surg Oncol
; 18(13): 3593-600, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21647761
13.
Utilization and Influence of Online Support Communities in Idiopathic Subglottic Stenosis Patients.
Laryngoscope
; 131(8): 1821-1827, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32990358
14.
Follow-up Interactive Long-Term Expert Ranking (FILTER): a crowdsourcing platform to adjudicate risk for survivorship care.
JAMIA Open
; 4(4): ooab090, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755049
15.
Barrett's Esophagus Translational Research Network (BETRNet): the pivotal role of multi-institutional collaboration in esophageal adenocarcinoma research.
Gastroenterology
; 146(7): 1586-90, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24768332
16.
Familial Aggregation in Idiopathic Subglottic Stenosis.
Otolaryngol Head Neck Surg
; 163(5): 1011-1017, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600122
17.
Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance.
Appl Immunohistochem Mol Morphol
; 28(9): 669-677, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31876606
18.
Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis.
JAMA Otolaryngol Head Neck Surg
; 146(1): 20-29, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31670805
19.
MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.
J Thorac Oncol
; 14(9): 1666-1671, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31228623
20.
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.
J Thorac Oncol
; 14(5): 876-889, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735816